Intravesical chemotherapy combination provides effective treatment alternative for high-risk non-muscle invasive bladder cancer
Newswise — July 27, 2022 – A combination of two intravesical chemotherapy drugs – gemcitabine and docetaxel – yields high response rates with good tolerability in patients with high-risk non-muscle-invasive …
Intravesical chemotherapy combination provides effective treatment alternative for high-risk non-muscle invasive bladder cancer Read More